Fmr LLC Geron Corp Transaction History

Fmr LLC

$1.52 Trillion
Q2 2024

A detailed history of Fmr LLC transactions in Geron Corp stock. As of the latest transaction made, Fmr LLC holds 15,355,776 shares of GERN stock, worth $69.4 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

15,355,776

Previous 12,760,298 20.34%

Holding current value

$69.4 Million

Previous $42.1 Million 54.62%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$3.1 - $5.09 $8.05 Million - $13.2 Million	2,595,478 Added 20.34%	15,355,776 $65.1 Million
Q1 2024 May 13, 2024	BUY	$1.75 - $3.44 $10 Million - $19.7 Million	5,727,946 Added 81.45%	12,760,298 $42.1 Million
Q4 2023 Feb 13, 2024	SELL	$1.74 - $2.31 $919,962 - $1.22 Million	-528,714 Reduced 6.99%	7,032,352 $14.8 Million
Q3 2023 Nov 13, 2023	SELL	$2.11 - $3.28 $723,660 - $1.12 Million	-342,967 Reduced 4.34%	7,561,066 $16 Million
Q2 2023 Aug 11, 2023	SELL	$1.97 - $3.69 $470,026 - $880,404	-238,592 Reduced 2.93%	7,904,033 $25.4 Million
Q1 2023 May 11, 2023	BUY	$2.14 - $3.4 $17 Million - $27.1 Million	7,958,208 Added 4315.33%	8,142,625 $17.7 Million
Q4 2022 Feb 13, 2023	SELL	$2.03 - $2.42 $35,159 - $41,914	-17,320 Reduced 8.59%	184,417 $446,000
Q3 2022 Nov 10, 2022	BUY	$1.67 - $2.94 $7,418 - $13,059	4,442 Added 2.25%	201,737 $472,000
Q2 2022 Aug 12, 2022	BUY	$1.19 - $1.65 $2,007 - $2,783	1,687 Added 0.86%	197,295 $306,000
Q1 2022 May 13, 2022	SELL	$0.99 - $1.6 $1.53 Million - $2.47 Million	-1,546,221 Reduced 88.77%	195,608 $266,000
Q4 2021 Feb 14, 2022	SELL	$1.22 - $1.72 $2.89 Million - $4.07 Million	-2,367,407 Reduced 57.61%	1,741,829 $2.13 Million
Q3 2021 Nov 15, 2021	BUY	$1.2 - $1.5 $36 - $45	30 Added 0.0%	4,109,236 $5.63 Million
Q2 2021 Aug 13, 2021	BUY	$1.25 - $1.83 $5.14 Million - $7.52 Million	4,109,206 New	4,109,206 $5.79 Million

Others Institutions Holding GERN

# of Institutions

257

Shares Held

448M

Call Options Held

1.91M

Put Options Held

897K

View Full List

About GERON CORP

Ticker GERN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 377,819,008
Market Cap $1.71B
Description
Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hemat...

More about GERN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fmr LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fmr LLC with notifications on news.

Account